These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 32189226

  • 1. The first case of gastric carcinoma with NTRK rearrangement: identification of a novel ATP1B-NTRK1 fusion.
    Shinozaki-Ushiku A, Ishikawa S, Komura D, Seto Y, Aburatani H, Ushiku T.
    Gastric Cancer; 2020 Sep; 23(5):944-947. PubMed ID: 32189226
    [Abstract] [Full Text] [Related]

  • 2. Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
    Zhao R, Yao F, Xiang C, Zhao J, Shang Z, Guo L, Ding W, Ma S, Yu A, Shao J, Zhu L, Han Y.
    J Pathol Clin Res; 2021 Jul; 7(4):375-384. PubMed ID: 33768710
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and detection methodology for preliminary exploration of NTRK fusion in gastric cancer from a single-center retrospective cohort.
    Dong K, Yin L, Wang Y, Jia L, Diao X, Huang X, Zhou L, Lin D, Sun Y.
    Hum Pathol; 2024 Jun; 148():87-92. PubMed ID: 38653403
    [Abstract] [Full Text] [Related]

  • 4. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I, Godschachner TM, Bergovec M, Igrec J, Till H, Lackner H, Scheipl S, Kashofer K, Brodowicz T, Leithner A, Szkandera J, Liegl-Atzwanger B.
    Mod Pathol; 2021 Feb; 34(2):396-407. PubMed ID: 32860002
    [Abstract] [Full Text] [Related]

  • 5. [Clinicopathological features of gastric carcinomas with NTRK-rearrangement/amplification: report of four cases].
    Xu AD, Fu Y, Pu XH, Wu HY, Sun Q, Fan XS.
    Zhonghua Bing Li Xue Za Zhi; 2023 May 08; 52(5):454-459. PubMed ID: 37106286
    [Abstract] [Full Text] [Related]

  • 6. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
    Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A.
    Pathology; 2022 Feb 08; 54(1):55-62. PubMed ID: 34518039
    [Abstract] [Full Text] [Related]

  • 7. Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing.
    Koehne de González A, Mansukhani MM, Fernandes H, Hsiao SJ.
    Cancer Genet; 2022 Apr 08; 262-263():47-52. PubMed ID: 35007853
    [Abstract] [Full Text] [Related]

  • 8. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA.
    Am J Surg Pathol; 2017 Nov 08; 41(11):1547-1551. PubMed ID: 28719467
    [Abstract] [Full Text] [Related]

  • 9. Colonic Adenocarcinomas Harboring NTRK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature.
    Lasota J, Chłopek M, Lamoureux J, Christiansen J, Kowalik A, Wasąg B, Felisiak-Gołąbek A, Agaimy A, Biernat W, Canzonieri V, Centonze G, Chmielik E, Daum O, Dubová M, Dziuba I, Goertz S, Góźdź S, Guttmejer-Nasierowska A, Haglund C, Hałoń A, Hartmann A, Inaguma S, Iżycka-Świeszewska E, Kaczorowski M, Kita P, Kołos M, Kopczyński J, Michal M, Milione M, Okoń K, Pęksa R, Pyzlak M, Ristimäki A, Ryś J, Szostak B, Szpor J, Szumiło J, Teresiński L, Waloszczyk P, Wejman J, Wesołowski W, Miettinen M.
    Am J Surg Pathol; 2020 Feb 08; 44(2):162-173. PubMed ID: 31567189
    [Abstract] [Full Text] [Related]

  • 10. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
    Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL.
    Am J Surg Pathol; 2018 Jul 08; 42(7):927-935. PubMed ID: 29683818
    [Abstract] [Full Text] [Related]

  • 11. NTRK Fusion in a Cohort of BRAF p. V600E Wild-Type Papillary Thyroid Carcinomas.
    Lee SE, Lee MS, Bang H, Kim MY, Choi YL, Oh YL.
    Mod Pathol; 2023 Aug 08; 36(8):100180. PubMed ID: 37003481
    [Abstract] [Full Text] [Related]

  • 12. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
    Rabban JT, Devine WP, Sangoi AR, Poder L, Alvarez E, Davis JL, Rudzinski E, Garg K, Bean GR.
    Histopathology; 2020 Jul 08; 77(1):100-111. PubMed ID: 31971278
    [Abstract] [Full Text] [Related]

  • 13. Myxoid Spindle Cell Sarcoma With LMNA-NTRK Fusion: Expanding the Morphologic Spectrum of NTRK-Rearranged Tumors.
    So YK, Chow C, To KF, Chan JKC, Cheuk W.
    Int J Surg Pathol; 2020 Aug 08; 28(5):574-578. PubMed ID: 32050835
    [Abstract] [Full Text] [Related]

  • 14. Limited Accuracy of Pan-Trk Immunohistochemistry Screening for NTRK Rearrangements in Follicular-Derived Thyroid Carcinoma.
    Macerola E, Proietti A, Poma AM, Vignali P, Sparavelli R, Ginori A, Basolo A, Elisei R, Santini F, Basolo F.
    Int J Mol Sci; 2022 Jul 05; 23(13):. PubMed ID: 35806472
    [Abstract] [Full Text] [Related]

  • 15. Detection of NTRK Fusions: Merits and Limitations of Current Diagnostic Platforms.
    Solomon JP, Hechtman JF.
    Cancer Res; 2019 Jul 01; 79(13):3163-3168. PubMed ID: 31196931
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).
    Chu YH, Dias-Santagata D, Farahani AA, Boyraz B, Faquin WC, Nosé V, Sadow PM.
    Mod Pathol; 2020 Nov 01; 33(11):2186-2197. PubMed ID: 32457407
    [Abstract] [Full Text] [Related]

  • 17. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE.
    Cancer; 2016 Apr 01; 122(7):1097-107. PubMed ID: 26784937
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
    Nozaki Y, Yamamoto H, Iwasaki T, Sato M, Jiromaru R, Hongo T, Yasumatsu R, Oda Y.
    Hum Pathol; 2020 Dec 01; 106():82-92. PubMed ID: 32980422
    [Abstract] [Full Text] [Related]

  • 19. A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types.
    Haberecker M, Töpfer A, Melega F, Moch H, Pauli C.
    Histopathology; 2023 Jun 01; 82(7):1003-1012. PubMed ID: 36759438
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.